esophageal squamous cell carcinoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with early esophageal squamous cell carcinomas or suspected esophageal squamous cell carcinomas Patients scheduled to undergo esophagogastroduodenoscopy at Nagoya University Hospital or participating facilities for the purpose of close examination or endoscopic treatment for early esophageal squamous cell carcinomas or suspected early esophageal squamous cell carcinomas Patients who have given sufficient explanation for participation in this study, and who have given written consent of their own free will based on sufficient understanding.
Exclusion criteria
Exclusion criteria: Patients who are deemed inappropriate as research subjects by the principal investigator Patients who are incapable of consenting Patients who will not be treated at their own institution Patients after radiation or radiochemotherapy for esophageal squamous cell carcinomas, radiation for head and neck cancers, esophagectomy, recurrence after treatment, advanced esophageal cancers, or adenocarcinoma of the esophagus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rates of CAD EYE (LCI-CADe and BLI-CADe) for known esophageal squamous cell carcinomas | — |
Countries
Japan
Contacts
Nagoya University Hospital Department of Gastroenterology and Hepatology